CUSIP: 34960Q109
Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,851,537
-
Share change
-
+869,443
-
Total reported value
-
$17,601,676
-
Price per share
-
$2.57
-
Number of holders
-
51
-
Value change
-
+$2,462,168
-
Number of buys
-
23
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2020
-
Previous quarter:
Q3 2019
Recent filing periods for CUSIP 34960Q109:
Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q4 2019
As of 31 Dec 2019,
FORTRESS BIOTECH INC - COM (FBIO) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,851,537 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Nantahala Capital Management, LLC, CPWM, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, SHIKIAR ASSET MANAGEMENT INC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.